Abstract | BACKGROUND AND OBJECTIVE: PATIENTS AND METHODS: Retrospective case series evaluating culture-positive streptococcal endophthalmitis from January 1, 2014, to December 31, 2019. RESULTS: Thirty-eight eyes met study criteria. The most common clinical setting was post- glaucoma surgery (33.3%, 12/36). The most frequent isolate was Streptococcus viridans (63.2%, 24/38). Isolates were susceptible to vancomycin (100%, 36/36), ceftriaxone (100%, 28/28), and levofloxacin (100%, 36/36). Final best-corrected visual acuity was 20/150 or better in 24.1% (7/29) but 20/200 or worse in 75.9% (22/29). Enucleation was performed in 11.1% (4/36). A subset (n = 11) of cases were evaluated for streptococcal-specific virulence factors: pneumolysin was present in 18.2% (2/11), autolysin in 45.5% (5/11), and hyaluronidase in 54.5% (6/11). Clinical setting, antibacterial susceptibilities, timing of pars plana vitrectomy, and virulence factor presence were not associated with better visual outcome or enucleation rate (P > .05). CONCLUSION: Visual prognosis for streptococcal endophthalmitis is poor despite early and appropriate antibiotic treatment. [Ophthalmic Surg Lasers Imaging Retina. 2021;52:182-189.].
|
Authors | Patrick C Staropoli, Harry W Flynn Jr, Darlene Miller, Patrice J Persad, Elizabeth A Vanner |
Journal | Ophthalmic surgery, lasers & imaging retina
(Ophthalmic Surg Lasers Imaging Retina)
Vol. 52
Issue 4
Pg. 182-189
(04 2021)
ISSN: 2325-8179 [Electronic] United States |
PMID | 34039183
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Anti-Bacterial Agents
- Anti-Infective Agents
|
Topics |
- Anti-Bacterial Agents
(pharmacology, therapeutic use)
- Anti-Infective Agents
- Endophthalmitis
(diagnosis, drug therapy)
- Eye Infections, Bacterial
(diagnosis, drug therapy)
- Humans
- Microbial Sensitivity Tests
- Retrospective Studies
- Streptococcus
- Visual Acuity
- Vitrectomy
- Vitreous Body
|